Discussions
Discussions
marsrocket Check-In 08/12/2025
Breaking news. Brensocatib has been approved by the FDA.
https://ktla.com/business/press-releases/cision/20250812AQ42418/fda-approves-brinsupri-brensocatib-as-the-first-and-only-treatment-for-non-cystic-fibrosis-bronchiectasis-a-serious-chronic-lung-disease/
Replies
Excellent news!!!
In case you missed the conference call;
A replay of the conference call will be accessible approximately two hours after its completion through August 19, 2025, by dialing (800) 770-2030 (domestic) or (609) 800-9909 (international) and referencing conference ID number 6364918. A webcast of the call will also be archived for 90 days under the Investor Relations section of the Company's website at www.insmed.com.
Product image.
Yippee 🥳!!!! SUCESS! The first drug for Non CF Bronchiectasis has been approved by the FDA !!! I look forward to hearing the positive results from patients in the near future! This drug approval is a great reason to celebrate 🎊!
According to someone who participated in the conference call, the company plans to have the medication available at specialty pharmacies in about a month. Here's hoping it helps many people.
Great news! Unfortunately, I didn’t get to listen in on the conference call. One month is not far away:).
Good news indeed👍
It is not our intention to serve as a substitute for medical advice and any content posted should not be used for medical advice, diagnosis or treatment. We make every effort to support our members, our medical professionals cannot and will not provide a diagnosis or suggest a specific medication; those decisions should be left to your personal medical team. While we encourage individuals to share their personal experiences with COPD, please consult a physician before making changes to your own COPD management plan.
Community posts are monitored by the 360social Community Manager, as well as staff respiratory therapists, educators, and other medical professionals.